Reproductive · PANCE / PANRE

Fibroadenoma

Benign fibroepithelial breast tumor — most common breast mass in women under 30.

Also known as: fibroadenoma, breast fibroadenoma, giant fibroadenoma

Overview

Benign biphasic (epithelial and stromal) tumor of the breast arising from the terminal ductal lobular unit. Most common breast tumor in adolescents and women under 30.

Epidemiology

Peak incidence ages 15-35. Found in ~10% of women at some point. Often multiple and bilateral. Spontaneous regression occurs in some, especially after menopause.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Fibroadenoma outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Adolescence and young adulthood (estrogen exposure)
  • Cyclosporine use (transplant patients)
  • Pregnancy and lactation (growth)
  • Black women (higher incidence)

Pathophysiology

Hormonally responsive benign neoplasm of stromal and epithelial elements. Growth driven by estrogen, often enlarging during pregnancy or with hormonal contraception. Histologic variants include simple (no proliferation, no increased cancer risk) and complex fibroadenomas (epithelial proliferation, cysts, sclerosing adenosis, calcifications — modest increased cancer risk).

Clinical presentation

Symptoms

  • Painless, slow-growing, smooth mass
  • Mobile under the skin ('breast mouse')
  • Usually solitary but can be multiple/bilateral
  • May grow during pregnancy or with hormonal therapy

Signs / physical exam

  • Firm, rubbery, well-circumscribed, highly mobile mass
  • Usually 1-3 cm; 'giant fibroadenoma' >5 cm
  • No skin or nipple changes; no lymphadenopathy

Classic findings

Young woman with a firm, rubbery, mobile, painless breast mass — well-circumscribed on ultrasound.

Differential diagnosis

  • Phyllodes tumor — Rapidly enlarging, may be very large; histology distinguishes — biphasic with cellular stroma
  • Breast cyst — Anechoic on ultrasound, fluctuant; aspirate
  • Breast cancer — Older patients, irregular and fixed; abnormal mammography; biopsy
  • Tubular adenoma — Similar to fibroadenoma but less stroma; benign
  • Lactating adenoma — Pregnancy/lactation; regresses postpartum
  • Hamartoma — Fatty and fibroglandular tissue; distinctive 'breast within a breast' appearance

Diagnostic workup

Imaging

  • Ultrasound — first-line for women <30; well-circumscribed, hypoechoic, oval mass with parallel orientation
  • Mammography for women ≥30 — round/oval mass with smooth margins; coarse 'popcorn' calcifications in involuting older lesions
  • Core needle biopsy — definitive diagnosis; recommended for masses >2 cm, growing lesions, atypical imaging, or older patients
  • Fine-needle aspiration may be used but core biopsy preferred to distinguish from phyllodes

Diagnostic algorithm

FeatureFibroadenomaPhyllodes TumorBreast Cancer
Typical age15-3535-55>40
GrowthSlowOften rapidVariable
Size1-3 cmOften >4 cm, can be hugeVariable
TextureFirm, rubbery, mobileFirm, mobile, may be lobulatedHard, fixed, irregular
Skin/nipple changesNoneSkin stretching with sizeDimpling, retraction
ImagingSmooth oval massLobulated mass, can be largeSpiculated, calcifications
TreatmentObservation or excisionWide local excision (>1 cm margins)Multimodality
Differentiating fibroadenoma from phyllodes tumor and cancer.

Treatment

First-line

  • Observation — for biopsy-proven simple fibroadenomas; clinical exam and imaging follow-up at 6 and 12 months
  • Reassurance
  • No restrictions on activities, contraception, or pregnancy

Surgical excision

  • Patient preference
  • Symptomatic, rapidly growing, or >3-4 cm
  • Atypia on biopsy or imaging-pathology discordance
  • Suspicion of phyllodes tumor
  • Cosmetic concern

Minimally invasive options

  • Cryoablation — FDA approved for small fibroadenomas (<4 cm)
  • Vacuum-assisted excision for selected lesions
  • Radiofrequency ablation (investigational)

Complications

  • Continued growth, especially during pregnancy
  • Complex fibroadenoma → modest increased breast cancer risk (~1.5-2x)
  • Phyllodes tumor misdiagnosed as fibroadenoma — wider excision required
  • Cosmetic deformity from large or multiple lesions
  • Anxiety from new breast mass

PANCE pearls

  • Simple fibroadenomas confer no increased breast cancer risk; complex fibroadenomas slightly increase risk.
  • Rapidly enlarging breast mass in a young woman — consider giant fibroadenoma or phyllodes tumor; excise.
  • Phyllodes tumor is distinguished from fibroadenoma by histology (cellular stroma); core needle biopsy may not reliably differentiate — excision often needed.
  • Coarse 'popcorn' calcifications in an older woman's mammogram suggest involuting fibroadenoma.
  • Adolescents with classic clinical and ultrasound features may be observed without biopsy with appropriate follow-up.

References

  • ACOG CO 821 — ACOG Committee Opinion 821: Benign Breast Conditions and Management
  • ASBrS 2019 — ASBrS Consensus Guideline on Concordance Assessment of Image-Guided Breast Biopsies and Management of Borderline or High-Risk Lesions

Practice Reproductive questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.